Benzinga - Tue, 04 May 2021 10:12:44 -0400
Benzinga - Mon, 03 May 2021 10:08:15 -0400
Benzinga - Mon, 03 May 2021 07:02:26 -0400
Benzinga - Fri, 30 Apr 2021 05:22:27 -0400
load more
Sector: Health Care.Industry: Biotechnology
Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company has primarily generated revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durability with treatment response, reduce the treatment burden of frequent anti-vascular endothelial growth factor (anti-VEGF) injections, and improve real-world vision outcomes for patients.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.380-0.290 0.0900
REV60.000K7.500M7.440M
Q4 2020Est.ActualSurprise
EPS-0.320-0.390 -0.0700
REV80.000K0-80.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ADVMAdverum Biotechnologies4.97%372.2M

Adverum Biotechnologies Company Questions & Answers

Q

How do I buy Adverum Biotechnologies (ADVM) stock?

A

You can purchase shares of Adverum Biotechnologies (NASDAQ: ADVM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Adverum Biotechnologies's (ADVM) main competitors?

A

Other companies in Adverum Biotechnologies’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), Outlook Therapeutics (NASDAQ:OTLK) and Fortress Biotech (NASDAQ:FBIO).

Q

What is the target price for Adverum Biotechnologies?

A

The latest price target for Adverum Biotechnologies (NASDAQ: ADVM) was reported by SVB Leerink on 2021-05-03. The analyst firm set a price target for 5.00 expecting ADVM to rise to within 12 months (a possible 31.58% upside). 8 analyst firms have reported ratings in the last year.

Q

How much is Adverum Biotechnologies (ADVM) stock ?

A

The stock price for Adverum Biotechnologies (NASDAQ: ADVM) is $3.8 last updated Today at 2:39:31 PM.

Q

When is the next Adverum Biotechnologies (ADVM) dividend?

A

There are no upcoming dividends for Adverum Biotechnologies.

Q

When is Adverum Biotechnologies (NASDAQ:ADVM) reporting earnings?

A
Adverum Biotechnologies’s Q2 earnings are confirmed after-market from now on August 9, 2021.
Q

When is the upcoming split for ADVM?

A

There is no upcoming split for Adverum Biotechnologies.